发明名称 DUAL RELEASE LEVODOPA ETHYL ESTER AND DECARBOXYLASE IN CONTROLLED RELEASE CORE
摘要 A tablet which comprises: an inner core formulated for controlled release comprising a mixture of (a) a granulated admixture of a decarboxylase inhibitor and a surfactant, and (b) levodopa ethyl ester or a derivative or a pharmaceutically acceptable salt thereof; and an outer layer encapsulating the inner core and formulated for immediate release comprising a mixture of a granulated decarboxylase inhibitor and levodopa ethyl ester or a derivative or a pharmaceutically acceptable salt thereof. The subject invention also encompasses a method of treating patients suffering from Parkinson's disease or related disorders by the administration of the pharmaceutical compositions of the subject invention. Additionally, the subject invention provides methods of manufacturing the tablets of the subject invention.
申请公布号 WO03005967(A3) 申请公布日期 2003.09.04
申请号 WO2002US22206 申请日期 2002.07.12
申请人 TEVA PHARMACEUTICAL INDUSTRIES, LTD.;TEVA PHARMACEUTICALS USA, INC.;LICHT, DANIELA;PATASHNIK, SHULAMIT;NAFTALI, EZMIRA;SAYAG, NAIM;GILBERT, ADRIAN;COHEN, SASSON;ZOLLMANN, CORINNE 发明人 LICHT, DANIELA;PATASHNIK, SHULAMIT;NAFTALI, EZMIRA;SAYAG, NAIM;GILBERT, ADRIAN;COHEN, SASSON;ZOLLMANN, CORINNE
分类号 A61K9/20;A61K9/22;A61K9/24;A61K9/26;A61K31/198;A61K45/06;A61P25/16 主分类号 A61K9/20
代理机构 代理人
主权项
地址